<SEC-DOCUMENT>0001213900-17-005949.txt : 20170530
<SEC-HEADER>0001213900-17-005949.hdr.sgml : 20170530
<ACCEPTANCE-DATETIME>20170530135745
ACCESSION NUMBER:		0001213900-17-005949
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20170530
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170530
DATE AS OF CHANGE:		20170530

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OptimizeRx Corp
		CENTRAL INDEX KEY:			0001448431
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				261265381
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-53605
		FILM NUMBER:		17876689

	BUSINESS ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
		BUSINESS PHONE:		248-651-6558

	MAIL ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k053017_optimizerxcorp.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WASHINGTON,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO SECTION 13 OR 15(d) OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
SECURITIES EXCHANGE ACT OF 1934</B><BR>
<BR>
Date of Report (Date of earliest event reported): May 30, 2017<BR>
<BR>
<U>OptimizeRx Corporation</U><BR>
(Exact name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevada</FONT></TD>
    <TD STYLE="width: 2%; padding: 0 0 1.5pt; text-align: center; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-53605</FONT></TD>
    <TD STYLE="width: 2%; padding: 0 0 1.5pt; text-align: center; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26-1265381</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of<BR>
incorporation)</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission
    File Number)</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer <BR>
Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 49%; padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">400
    Water Street, Suite 200, Rochester, MI</FONT></TD>
    <TD STYLE="width: 2%; padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 49%; padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48307</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&rsquo;s
telephone number, including area code: <U>248.651.6568</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 40%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 5%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0">&#9744;</TD>
    <TD STYLE="width: 95%; padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0">&#9744;</TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0">&#9744;</TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0">&#9744;</TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company&nbsp;&nbsp;&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
8 &ndash; Other Events</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
                                         8.01</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
                                         Events</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 30, 2017, we issued a press release concerning the invitation for our CEO, Will Febbo, to present at the 7th annual LD Micro
Invitational. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in Item 8.01 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed &ldquo;filed&rdquo; for
purposes of Section 18 of the Securities Exchange Act of 1934 (the &ldquo;Exchange Act&rdquo;) or otherwise subject to the liabilities
of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange
Act, except as expressly set forth by specific reference in such a filing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
9 &ndash; Financial Statements and Exhibits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
                                         9.01</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial
                                         Statements and Exhibits</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0; text-indent: 0; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="padding-left: 0; text-indent: 0; width: 90%"><A HREF="f8k053017ex99i_optimizerx.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press release, dated May 30, 2017</FONT></A></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OptimizeRx
Corporation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 40%; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0; text-decoration: none; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Doug Baker</FONT></TD>
    <TD STYLE="width: 60%; padding: 0 0 1.5pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Doug
    Baker<BR>
    Chief Financial Officer</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    May 30, 2017</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>f8k053017ex99i_optimizerx.htm
<DESCRIPTION>PRESS RELEASE, DATED MAY 30, 2017
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: right; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><B>Exhibit 99.1</B></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><IMG SRC="ex99i_001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OptimizeRx
to Present at the 7<SUP>th</SUP> Annual LD Micro Invitational on June 7, 2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rochester,
MI (May 30, 2017) </B>OptimizeRx Corp. (OTCQB: OPRX), the leading aggregator of pharmaceutical-sponsored services in electronic
health record (EHR) platforms, has been invited to present at the 7<SUP>th</SUP> annual LD Micro Invitational being held on June
6-7, 2017 at the Luxe Sunset Bel Air Hotel in Bel Air, California.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OptimizeRx
CEO William J. Febbo is scheduled to present on Wednesday, June 7 at 12:00 p.m. Pacific time, and participate in one-on-one meetings
with institutional analysts and investors on June 6-7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
CEO will present the OptimizeRx digital health platform, the industry's largest point-of-prescribe promotional network with more
than 370 EHR partners reaching over 500,000 health care providers. Working in partnership with some of the world's largest pharmaceutical
and health care companies, OptimizeRx been revolutionizing the point-of-care for physicians and their patients. A 20% expansion
of the OptimizeRx EHR network in Q1 2017 drove a 22% increase in revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
presentation will be webcast live and available for replay <U>here</U> and via the Investor Relations section of the company&rsquo;s
website at <U>www.optimizerx.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">View
OptimizeRx&rsquo;s profile at <U>www.ldmicro.com/profile/OPRX</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
year&rsquo;s LD Micro Invitational will feature presentations from 180 companies in the small- and micro-cap space, along with
Q&amp;A sessions, expert panels, and one-on-one and small group meetings. The event is designed to provide investors with a unique
opportunity to gain insight into emerging growth companies across a variety of industry sectors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
those interested in attending and scheduling a meeting with OptimizeRx, please contact LD Micro or visit <U>www.ldmicro.com/events</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
LD Micro</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LD
Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a
newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually
(Invitational, Summit, and Main Event).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector.
LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe. For more information,
visit <U>www.ldmicro.com</U>.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About OptimizeRx Corp</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
in Rochester, Michigan, OptimizeRx Corporation is a health technology software company that is revolutionizing the point of care
experience through technology to improve clinical decisions and outcomes. OptimizeRx&rsquo;s unique consumer and physician platforms
help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical and healthcare
companies effective ways to expand awareness, access and adherence to their medications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: right; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
OptimizeRx core product replaces drug samples with electronic trial vouchers and copay coupon savings that are electronically
added to an e-Prescription and sent electronically to the pharmacy and is integrated within leading electronic health record (EHR)
platforms in the country, including Allscripts, DrFirst, NewCrop, Quest Diagnostics, Practice Fusion and other EHRs to reach over
500,000 healthcare providers. In turn, OptimizeRx promotes patient savings and support from the world&rsquo;s largest pharmaceutical
companies, including Pfizer, Lilly, Novartis, AstraZeneca, and many others. For more information, visit <U>www.optimizerx.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Important
Cautions Regarding Forward Looking Statements</B></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This press release contains forward-looking
statements within the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities
Act of 1934, amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,'
'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement
was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of
new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some
of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in,
contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements
are subject include, but are not limited to, the effect of government regulation, competition and other material risks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OptimizeRx
Contact:&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Doug
Baker, CFO&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel
(248) 651-6568 x807&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dbaker@optimizerx.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Relations Contact:&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ron
Both&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CMA&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel
(949) 432-7557&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">oprx@cma.team</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99i_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99i_001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  V 10# 2(  A$! Q$!_\0
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M/DG)4XS\;!Y)C,=A:V*H>S:H5O8SISDXSYKP4G=I4XP@I.4YSG%1C";>RO\
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M\*RJC.BR! ZJ[JK!78']QO\ @YH\7_\ !23PYX!^$NG?L46GQMG^".N_"O\
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MQCR2IQ514I2Q4[:I.5^:\K13>EK'ZQT5_G2_\)C_ ,'<'_/C^V=_X1'P<_\
ME%7R=^TC_P %'?\ @X<_8_U'POH_[3OQ]_:!^"NK^-;+4-2\*Z3XUT+X/VNJ
M:UINE3P6M_J%KI]EX8OKM+""ZN8K87ES#!;3W F@MI9I;>X2+7!^ 68YCB(8
M3+^/O#S'XNHINGA<%G-;%8BHJ<7.;A0P\*U62A!.<W&FU&*<I-+4WI<-U:]2
M-*CF>55:DK\M.GB92G*R;=HJG=V2;TZ(_P!0NBOY@?\ @V2_:9_;Z_:W^#O[
M2OQC_;(^(GQ ^*'@.Z\9> /#7P%\7>--)\.:3I]_/H%EXS7XJ)X4.A:'H;ZI
M8V6I77A33]3U.2.[L!JUI<:997(O=-U>"'X3_P""Q'_!R+\8/#/QP\1_L8_\
M$SXK";Q-X9\32_#CQI\>;7PW;_$'Q+X@^)!O3HEYX"^!?A2>VU71[V72]9D.
MA7'BO4-'\076M>(HY['PGI5O;V5MKVK?(T/"?B;&\:YIP1EM3+<PQF2\D\US
M6CB9T\EP%%T:-6I5Q6+K4^>G[&55X>5'V;Q$\32K4H4U[*K.CPQR;%U,PJY=
M1=*K5H?QJT)_[/2BDG.4ZLDE&,-5*^O,FDF]O[:J*_S@_$?AW_@ZZ^$G@J7]
MI3Q!XI_;43P]IUI=>*=5TEO'G@OQWJFBZ7##)?7E]K?P&M]3\07MII]I:K)<
M76E/X&=]*MXW^U:;8K;N(OW%_P""#W_!P1K7[=GB^#]DC]K^#PQHW[2<VD:A
MJWPO^)/AJPB\/>&_C99:)9RZAKF@:KX=BD;3_#OQ(TO2H+G7(8]$^S^'O%&C
MV>IR6&EZ%?Z0;/5?0S[P<SG*\DQW$&3Y]PSQCEV4MK.'PSCWB\1E<8_'5KX>
M3G*="DE*56I2FI0I1E7]G4H0JU*6F(R3$4</4Q5'$83'4:+M7>#K>UE17252
M-E+DO?WDFE:[TU/ZJ=4)73-1*DJ18W9!!(((MY""",$$'D$'(/(K^?W2]8\;
MZO>V.EZ7K?BK4-2U&>"SL;&UUK5Y;F\N[AECAMX(EN]TDTKD(B+RS$ 5_0#J
MO_(+U+_KPO/_ $GDK\(O@CQ\7?A<1U_X3;PW_P"G""O\*/VG-'&9GQY]%WAR
MAG.;Y-A>)L\X@R+'8C)\?B\%7C0SCBOPUR>IB(QP^.PE&M7PU#-J]7#+%1JT
MU5A&,N6G.JI7D[4:>-FXQDX0A)*235XPK2MJFTFXI.QU?_"KOVDO^A5^*_\
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MYKQEXG?22RGPCX4X.R?A'%X7A7 <#XWCJ?$F>\08[$T95(8VEQEAL#0P.6+
MX2E@<%RX.OCLPS?,J=2G0H9?EF,JU]\EP=++%6SG$+%8:C1H5:=..*A3ISKS
MK0Y8QI4T^:?2S:2;:Z<S7],'_!2CQCX/T/\ X-L+#X07/BF"[\?^&/V7_P!C
M7P]J^C26^H)>P:SHVL_!S^U;&5Y;"V@$NGM:W4,HW+M-L4Y?:&_*#_@TN^#/
MP.G^,7[2?[4WQ6.CW7C/X/:-X&\ _!^+4[*XU*;P[J/Q#3Q1?>-O%VG6T5M<
M1V>L?V-X?TGPYINJ;5NH-.U?Q+:V[QQW=QO_ 'V_X.#O@#\,/ __  22_:J\
M2>'-&O+'5-/@^%0LV.LZG/;0K-\8O 5FR"TN+F2W,:6T\D<2%,1C:4QMY_BX
M_P""(_\ P44^'G_!/W]HGQ#<_'_0/$FM?LV?&O2=)\(_$;4_"R:A/K7@3Q!H
M-Y<:EX0\>Z?IMB1)K\.D17^N:9K^@6N[5;C0M:N=4TN&]OM(M],O^KPNI_2>
MXJ^BCXR_\)?A9A_&/,_$#,,7PWE&0YCQ)7X3QW#=>OP]F.8Y=CL9BXX7-(YU
M6R[$9UAJ4<-".%Q53!X2FZ48YC.E3O+Z7UOA_-8X-XA^UQ;J5()05:I?DJ5*
M5-)I2YD[*.\TG%*[5_\ 493XX?#&3_5^)%?C/RZ;JO/; S9#))X '>O\P3_@
MX)^#?PT_9N_X*E_$S4_V>H[?PIX;\?Z'\/\ ]H/2M*\/VCZ+:>#_ ![XH%Y<
M^(Y-#M@D']G17GB_P_<^,K6&UAM[33[K79+6QAAM[6*-/[>?&/\ P50_X(K>
M!/AK<?%%OVS_ (=^(M)339M1T_POX*\5:MXH^(VL2QPR3PZ58?#NSL'\76VJ
M7DD?V>.'6M,TFWMKB1/[2NK" /-'_!-\9?%?Q2_X+9_\%1XK?X3>"M5T:Z^/
MGCOPYX ^&OA*ZN6U>X^''P;\*6L&FKKWBK4(5>WB3PUX0L=6\>>-KN#=86^I
M3ZK!8O<*UH)\_H?Y1])+)^-^(,]\8<EX)X9\/L!PAG-+-\1E/]OX>OBLUC5P
M5;+J2HYY2PM.IA\%1H9OBL755"K[*#HT55]IB_8U<.&\.\/B,7BG#$T<)2P=
M>.(GB8>RI.\'R1M*,?:24DY6479=6VE+_1/^._[06D_%7_@D=\6/'&O7[1>+
M?B9_P3H\7>,]7MH[*]\I=>\;_LW7NN7MO',+98MHO]5D0-E4"?,<+7\:?_!I
M-J=GI'_!1GXFW%]*T43_ +)?CJ)66.23+K\0OA7.05C5F $<,C9(QE0.I%?V
MW?M;_LT^$/"7_!/3]I'X?>!M.UF\;PC^QG\5O!'@[3(+AYKBXB\,?!/6M!\/
M6,%I!"6GN)HM.L[=+:)29Y6\J-077'^?-_P;K_M;_LX?L@_MXWWC+]J'QROP
MT^'/CSX&^,OAS9>.KRWO9?#^@^*=1UKPCX@TO_A)I]/M;Z[TW2=2L_#VI:;%
MJGV62TM-5N=-&H26ME+->6_N^#E/Q(S;P6^D5AZV5\/3SS$XZ,^#LKR66*Q5
M.I@)TZ]?#4<?3]ZO*O3P<*,.7#QES3P]94XR:C%Y93"%;)^(88>-2?,J<HTX
MQO/E4G)<L8W=E%:I7LE;6VO^HB/&OAUL%;R0AB "+2ZYR<#K"#C\/IGBO\N_
M]ON5'_X.(_B+,IS'_P /"/@LV<$<1^,?AB'X(SP4;MSCC.17^B1^RS^UQ^Q7
M^VGJ/Q#T[]E?XTZ9\:8_A*?"R>.M4\*1ZZ= T>Y\8IKD^@6,6N:GHNG:=JUW
M/#X>U*:XBT:YOA8+'$EZ\$L\<9_SMOV^H4C_ .#B+XBP#)3_ (>#_!9>3SB3
MQC\,2W( [N<<<<5V_1DPG&V XEX_PG%^7X'+<32\/<Q:PM&GB:.)IUZDYU*?
MMZ&*C"K3ISHS52//3A)QE"5K25\N&X.GB\QA*,X3658OW:D7%I.%U=-)IO3I
ML?U>?\'9]S#/_P $NO#B1L6:+]K3X1*X*L,$>#_BNIY(&>?3-?+7_!H#\//A
M_P"'OV8_VJ_CC<:9:_\ "P?$_P <=)^&=WX@>S%QJ-MX*\&^!- \3:;HMG<B
M)Y[:RNM<\7ZOJ.HV]NR1WUQ;:9)=K*VGV1A^H_\ @[-M8K?_ ()=^'7CW;IO
MVM?A$S[B",MX/^*[': !@9]<\5Y#_P &B6D6FJ_L#_M"K=&8#_AK#6D/E2>7
ME5^$_P ,L<[3_P ]WR1@]/3GK]OGE+Z*N9?4'A8YA6X\IT)0J5)QPU3"SS/"
MSJTZCC)2DI.C2ER-N,I4X\R=DA4Y-<(UE=J,LTC&5GJXWND^Z;46UY>1]=?\
M',N@_#KXB_\ !)3XT:UJ]C#J/B'X9^-OA#XT\":C-8L+O0_$5Q\0]#\)7UQ:
M7,T(>W6_\+>)/$&EWB1NJW%M=E'W$1X_$W_@S]\&_#:S\;?MI?&OQ-8VLOCK
MPOH'PE^'GA+6)K&2\N]%\/>+;OQGKGBZ+3I$AE-H^LWGAKPQ'>21E)98--2$
M-Y+3J_[Q?\'&WA/2M,_X(]_M4W5L;LRPW/P<D3S9PZAC\:? 4!ROEKD>7._4
MYW;3GC!_%_\ X,]?"FE^)O#'[>HU(W8^S>(/@#'%]EG$'RSZ9\4'DW?NW).Z
M&/:05VC=P2<CQ\AQGB!3^B?XCK#?V*N(8\983#971GB,0LJ>6XG&<+RQE/$2
MC/VD)5H_6I2ITW&G4FJ?/%\\^:\).W"N8KGJ*'UZE%I/I+V3:2O91DTG)+=[
MIG]!/_!:=/A/\:_^"67[;7A76TM=:?1/@CXE^('AU[W2;EFTOQ=\/#;^+?#&
ML:;=7%FQLKZUU?2K>$75NT<K6MQ=VDDGV6ZN4?\ E:_X-"_%VF^%/VH_VOKC
M6M0FLM*N/V>O!TDB)'<SPR7<'Q+MHK>1X+:.0M+#'>3)%(4)1)Y@I =P?ZW/
M^"K/PM\*Z)_P3/\ V\+^Q341-;?LL?&.6)9;YI(P\/A#4;A-RF/+#S(DW M\
MR[ER,Y'\BW_!HIX4TCQA^U-^USI>LK<M:K^SKX2G M;AK:3S%^)VGD$R*"2/
MD4;3\N,\9((^=\/,3XNS^B[X^0QE#@U\58?-LGEPAAH8C&RR%PK4L@EBY9M)
MRE5I5)2IXB4?JZCS2IX=RN[LG 2I_P"KF<1YJOLUBL%S+2ZYM^17M[S2OIK9
M7\OB_P#X.>=<TSQ)_P %8OB3JFC7(O+&?X+_  -CCG$<L6YT\)7)==DZ1R K
MYBYW*!D\$X-?Z,WPC^//PFL/A'\*H+OQ?;12Q_#;P(KH=/U=F5O^$5TIMI\N
MP=<@$9PQ )P3FO\ .3_X.<?#VF^%?^"KWQ'T?2%G2RM_@Q\#I8UN)FN)=\GA
M*X#%I7&X@B-<#H.<#G _NP^.7C+]D3]B3]B'1_VGOV@KO6=*\&>#_A9X!$.G
MV&M:C+KOC#Q5J7A738/#?@CPIIZ7,1OO$?B6_C6TL(7EAL[5!<ZIJ=Q9:387
MUY;^=X^4_I!XSP:^BW@_#K*/#;,>-,?P[B\-Q9@<_P 5GT<L_M6ME^2PPM'A
MG^S(RQ6(HU,9+$PG];M)452G>*C5E"\RA0J97P[3MB)<]'$QHQIQC*<G*NDD
MT^K;T2-?_@H5_P %;?V7OV ?V>_$7Q?\2^);7QMXVNHKO1OA-\)]*-[9Z]\2
M?')MEDM-+AGNK)$TSP]I?G0:CXO\12K)#H>CAC'#>ZO=Z3I6H_P>?L7?LX?&
M/_@NK^W;XT_:8_;7^)\_AKX+6GB2RUCXT>/7FO-+@N-(M)5D\-?L[? ^U*7D
M>DI#I12P#P&2/P9X8-[XFU2;4?%6JV2:W\LZ_P#%R;_@KC^WW8^(?VH/CW\/
M?V2?@AJ>I7TJZQX[\4R#P;\"_@QI%TEPO@KP''J8>3Q;\0]6M3#;6\TT$,GB
MGQ;=7/B'7)-/T&QEBL/[C?@C^T9_P;R_L\_"SP7\'/A=^U9^SMHG@GP-ID>G
MZ9:R?%C5IKW4;ECYNI:]KUZDL+:KXAUZ],NHZUJDJ(]W=S,$C@MH[>VA]C.L
MM^DIX(>"F6X/@/A7PVXO^E%Q@J;XIS>I2X]PGAEX?<-XBK7J5,OR3&9;DV?9
M]GV>TJ$<-@Z=>-7*L+B\S>-SO$T*&599D.59EU_5Z>0494J5'&U,QQ=%>TKT
M<.ZSP=&:_A4Y\GLXUIZ\\HN3C:U]+'W!^T]^T)\!?V1_^"=OQ_A_9GUKP)X,
MB^!'[+/Q'B^"_@[PH?[-T_PU?>&_ 6J6O@NWTNT6-'+V&K'3[H^9(U[?7*R3
MW5Q)=3S7!_SD/^".?[:/[,G[!/[7J_M2_M1?#'XA_&&?P=X(U^W^$^F^"8/"
M^HWNB?%#Q)=V-C=>.=77QCK6C6TD^G^%)?$UIIEU!<S7UMJ^MKJ4:)/;17$7
M^B1X1\,_\$SO^"COP9_:$^%O[-WQ*^'7Q;T[4? 6K_#GQUKGP[\7ZUK\_@63
MXG>&_$.E:#J%TC7Z117;?9-0U'3$D5TFFTB4$8C85_GV_L-^+? G_!*S_@I5
MXE^%_P#P46^ FB>/?AYX9OO$?P3^./ACQ1X-M/&,WA6"[OM/OO#7QC\&Z1?V
MD\FM:? UCI?B&QETI'G\1^ -?OYM'CN[Z:P@?O\ HL5/&NIX:^..2>,G"7 N
M.\2JM7+\?E7"_A[Q1QCD6(XAX>J94UC\+F>=\9Y!B,VRS,IYK5QDH5<)E684
M,5AL93IUHQQ&91K-9)'"RPF=86-+&U<14I4ZE2A-JABZU)7<XTY1O-MMN4HN
MTI<V[4C^J+_B,)_8;_Z-K_:G_P# ;X3?_/&K^/GQI^UE\+#_ ,%7]._;+_9)
M\+:_\(OAU<_M4_#[XT^"/!7B*#0=,U/PQ/?>(_#NK>.=%FL?#VH:CH-GH>JZ
M[/XKCM=.L;U[2#P[JT=@1"J-&G^@3I?Q _X-T=2\#P_$>R\5?\$SAX7;3SJJ
MO?ZA\'-/U]+9$\UDN/!>K/;>,H+Y0"KZ3=>'TU-908'LA*#&/DS]C_\ X*)?
M\$*OVM_VS=:_8_\ A3^R3\&=,U.6:V@^!?Q7U[]G;P':>%/CEX@TFROM4\3Z
M9X8MI_"H\3>%+C1[:Q.H>&[OQ;:::GBJRM=3NH?[*N;33K36/IN">+,]X;H\
M58[*/H\9YE^&>18O!Y_/&>)^8YI@89?-585)8G"X_P +\DA*="=:;E+#O%8B
MEA7BZBA&DIU(<V#Q.%P<<94PF39CRRPU2CBG6JU)4HT9M1<IQG2A&\6]'=V>
MOFOZ:+GQ)X=U#3;]=/U[1;YI+"[\M;/5+&Y:3-M(1L$,[E\CD;0<CD<5^#/@
M+Q'%X/\ &7A+Q5/:27T/AS7=+UF6RBE6"6[33[B.=K>.9TD2)Y0A59&1U4D$
MJ17[EGX;_#W1+"\GT?P-X1TV>"RNF@N++P[I-O<1,D$A1XYX[19492 597#
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M6?$6@1V4VMZ+IWBW2+G2+O4M*BU&&XL)+^TAN6FMEO()K<RJOFQNF5/Y;?\
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M\-;"+F]R,8_[1]9O9;O5Z?7L5;#+V\[8.[PJO']Q=\SY--+O5WOKKH?R0?\
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M:G\,+K4]06S^$*:!I6NP^,KKPSKEQH(T?5=*U&P\&Z/JLNNPZY';V]DWQ_\
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3[UMHK+?8HHHK^@SE"BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
